ATE467130T1 - Verwendung von xcri zur diagnose oder überwachung von immuntoleranz - Google Patents

Verwendung von xcri zur diagnose oder überwachung von immuntoleranz

Info

Publication number
ATE467130T1
ATE467130T1 AT06724890T AT06724890T ATE467130T1 AT E467130 T1 ATE467130 T1 AT E467130T1 AT 06724890 T AT06724890 T AT 06724890T AT 06724890 T AT06724890 T AT 06724890T AT E467130 T1 ATE467130 T1 AT E467130T1
Authority
AT
Austria
Prior art keywords
measuring
expression level
cell sample
xcri
diagnosing
Prior art date
Application number
AT06724890T
Other languages
English (en)
Inventor
Thilo Oelert
Bernd Arnold
Guenter Haemmerling
Original Assignee
Dkfz Krebsforschungszentrum
Univ Ruprecht Karls Heidelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dkfz Krebsforschungszentrum, Univ Ruprecht Karls Heidelberg filed Critical Dkfz Krebsforschungszentrum
Application granted granted Critical
Publication of ATE467130T1 publication Critical patent/ATE467130T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Eye Examination Apparatus (AREA)
AT06724890T 2005-03-01 2006-02-27 Verwendung von xcri zur diagnose oder überwachung von immuntoleranz ATE467130T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05004392A EP1698902A1 (de) 2005-03-01 2005-03-01 Verwendung von XCR1 zur Diagnose und Überwachung der Immuntoleranz
PCT/EP2006/060285 WO2006092385A2 (en) 2005-03-01 2006-02-27 Use of xcr1 for diagnosing or monitoring of immune tolerance

Publications (1)

Publication Number Publication Date
ATE467130T1 true ATE467130T1 (de) 2010-05-15

Family

ID=34933993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06724890T ATE467130T1 (de) 2005-03-01 2006-02-27 Verwendung von xcri zur diagnose oder überwachung von immuntoleranz

Country Status (5)

Country Link
US (1) US20100087630A1 (de)
EP (2) EP1698902A1 (de)
AT (1) ATE467130T1 (de)
DE (1) DE602006014103D1 (de)
WO (1) WO2006092385A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2062592A1 (de) * 2007-11-20 2009-05-27 BUNDESREPUBLIK DEUTSCHLAND letztvertreten durch das Robert Koch-Institut vertreten durch seinen Präsidenten System zur Abgabe in eine positive XCR1-Zelle und Verwendungen dafür
US20120083007A1 (en) * 2010-10-01 2012-04-05 Nadeau Kari C Basophil Activation Based Allergy Diagnostic Test
US9946836B2 (en) 2011-01-31 2018-04-17 Robert Bosch Gmbh Biomarker monitoring device and method
JP5989096B2 (ja) * 2011-09-01 2016-09-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗ヒトｘｃｒ１抗体
US20130245236A1 (en) * 2012-03-15 2013-09-19 Richard Kroczek Antibodies to the chemokine receptor xcr1
US12410225B2 (en) 2018-11-08 2025-09-09 Orionis Biosciences, Inc Modulation of dendritic cell lineages

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001250412A1 (en) * 2000-03-31 2001-10-08 Ipf Pharmaceuticals Gmbh Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using specific chemokine receptor analysis and the chemokine receptor-ligand interaction
WO2002012343A2 (en) * 2000-08-07 2002-02-14 Curagen Corporation Proteins and nucleic acids encoding g-protein coupled receptors
WO2002059608A2 (en) * 2000-11-29 2002-08-01 Lifespan Biosciences, Inc. Compositions and methods related to chemokine (c motif) xc receptor 1 (ccxcr1)
US20030124627A1 (en) * 2001-11-29 2003-07-03 Burmer Glenna C. Diagnostic and therapeutic compositions and methods related to chemokine (C motif ) XC receptor 1 (CCXCR1), a G protein-coupled receptor (GPCR)
WO2004045525A2 (en) * 2002-11-15 2004-06-03 Morehouse School Of Medicine Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation.

Also Published As

Publication number Publication date
EP1861718B1 (de) 2010-05-05
WO2006092385A2 (en) 2006-09-08
WO2006092385A3 (en) 2007-03-22
US20100087630A1 (en) 2010-04-08
DE602006014103D1 (de) 2010-06-17
EP1861718A2 (de) 2007-12-05
EP1698902A1 (de) 2006-09-06

Similar Documents

Publication Publication Date Title
DE60332639D1 (de) Verwendung von biomarkern zum nachweis von eierstockkrebs
TW200617380A (en) Concentration determination in a diffusion barrier layer
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
WO2006129131A3 (en) Biomarkers for psychotic disorders
NO20070598L (no) Anvendelse av transtyridin som en biomarkor for colorektal adenom og/eller karsinom, samt deteksjonmetode og testsytem
WO2009063840A1 (ja) エンドトキシンの濃度測定方法および濃度測定用キット
WO2012120288A3 (en) Method, array and use for determining the presence of pancreatic cancer.
BRPI0814202A2 (pt) Métodos e sistemas de determinação de concentração de produto de análise em amostra fluida e meio legível em computador
CN102708306A (zh) 一种智能电表可靠寿命的预测方法
RU2010128653A (ru) Компенсация на основе наклона
EA201190026A1 (ru) Ценный документ, способ изготовления контрольного элемента и способ обнаружения загрязнения или истирания документа
WO2017050939A3 (en) Method and array for diagnosing pancreatic cancer in an individual
WO2017194613A3 (en) Method, array and use thereof
WO2012122236A3 (en) Method and system to detect and diagnose alzheimer's disease
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE467130T1 (de) Verwendung von xcri zur diagnose oder überwachung von immuntoleranz
DE502004003894D1 (de) Bezugselektrode für potentiometrische Messungen und Verfahren zu deren Überwachung
DE602006021777D1 (de) Diagnoseverfahren für präeklampsie
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
BR112012024175A2 (pt) hbf e a1m como marcadores de estágio precoce para preeclampsia
WO2011063389A3 (en) Normalization of platelet biomarkers
CN113160903A (zh) 一种基于迁移学习的硝酸盐浓度预测模型泛化方法
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties